As a result, the current findings reveal that linagliptin has renal benefits irrespective of glucose control
Food and Drug Administration (FDA) generally classifies GLP-1 receptor agonists as Category C drugs for pregnancy, meaning that animal studies have shown potential risks, but there are no well-controlled studies in pregnant women
The MHRA also operates an Innovative Licensing and Access Pathway (ILAP) , designed to accelerate access for promising medicines with significant unmet need
Higher ambient temperature and increased levels of noise, carbon dioxide, particulate pollution, and light pollution have all been associated with worse sleep quality in healthy adults
Kim 1 , Agustina Reca 1 , Trevor Crafts 2 , Bruce Wolfe 2 and Ariel E